Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan

Sexually Transmitted Infections

Volumn 80, Issue 2, 2004, Pages 105-107

  Shigemura, K ^b   Okada, H ^a,b   Shirakawa, T ^b   Tanaka, K ^b   Arakawa, S ^b   Kinoshita, S ^b   Gotoh, A ^b   Kamidono, S ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; GONORRHEA; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; JAPAN; MALE; NEISSERIA GONORRHOEAE;

EID: 1942425952     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.006908     Document Type: Article

References (11)

1. De Schryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ 1990;68:639-54.
2. Gorwitz RJ, Nakashima AK, Moran J, et al. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae United States, 1988-1991. Morb Mortal Wkly Rep 1993;42(SS-3):29-39.
3. Tanaka M, Nakayama H, Haraoka M, et al. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J Clin Microbiol 2000;38:521-5.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Informational supplement. M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
5. Moodley P, Pillay C, Goga R, et al. Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management. J Antimicrob Chemother 2001;48:853-9.
6. Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonum) resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 2001;45:3603-6.
7. Dragsted D, Poulsen P, NØrgaard C, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Nuuk, Greenland during 1998-1999. Int J STD AIDS 2002;13:826-8.
8. Chalkley LJ, Rensburg MNJV, Matthee PC, et al. Plasmid analysis of Neisseria gonorrhoeae isolates and dissemination of tetM genes in southern Africa 1993-1995. J Antimicrob Chemother 1997;40:817-822.
9. Deguchi T, Yasuda M, Yokoi S, et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother 2003;9:35-39.
10. Tanaka M, Nakayama H, Tunoe H, et al. A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimen for the single-dose treatment of gonococcal infection in Japan. J Infect Chemother 2002;8:81-6.
11. World Health Organization. Programme for sexually transmitted diseases, global programme on AIDS. Recommendations for the management of sexually transmitted diseases. WHO/GPA/TEM/94. Geneva: WHO, 1994.